Pilonidal disease and skin abscess: I&D first, antibiotics selectively

Pilonidal disease and skin abscesses are among the most common procedural presentations in general practice. The acute management principle is straightforward — incision and drainage (I&D) is the primary treatment, and antibiotics are an adjunct reserved for specific indications rather than a routine add-on. What separates good outcomes from recurrence is the technical detail: an off-midline incision for pilonidal abscess, adequate cavity drainage, hair removal as follow-through, and early recognition of the patients who warrant investigation for underlying immunodeficiency or S. aureus carriage.

Therapeutic Guidelines and the IDSA 2014 practice guidelines both emphasise that antibiotics without drainage are insufficient for fluctuant abscess, and that drainage without antibiotics is sufficient for most uncomplicated presentations in immunocompetent adults.

A. Core clinical — pilonidal disease and cutaneous abscess in general practice

Pilonidal disease is a chronic inflammatory condition of the natal cleft, driven by free-floating hair shafts being drawn into hair follicle openings by friction and suction during sitting. The entrapped hair provokes a foreign-body reaction, granulomatous inflammation, and eventually sinus tract formation. Acute pilonidal abscess occurs when a sinus becomes obstructed.

The condition is most common in young men aged 15–30 (male-to-female ratio approximately 2.5:1). Risk factors include hirsutism, a deep natal cleft, obesity, sedentary occupation (military personnel, drivers), and a positive family history. The natural history after a first I&D is that 40–50% of patients develop recurrent disease without definitive intervention.

Cutaneous abscesses elsewhere on the body (back, buttocks, axilla, groin, extremities) most commonly arise from Staphylococcus aureus, including community-acquired methicillin-resistant strains (CA-MRSA). Streptococcus pyogenes is the other major pathogen; perianal and genital abscesses carry mixed flora including anaerobes. A furuncle is a single follicle-centred abscess (“boil”); a carbuncle is a coalesced multi-follicle abscess with multiple draining points.

Diagnosis is clinical. Imaging is reserved for deeper or complex anatomy (perianal, ischiorectal), diagnostic uncertainty, or pre-operative planning for recurrent disease. Bedside ultrasound reliably differentiates a fluid-containing abscess from cellulitis without a drainable collection. Culture and sensitivity swabs are indicated for recurrent abscesses, antibiotic failure, and immunocompromised patients.

Acute management — I&D technique:

• Local anaesthetic (lignocaine 1–2% with or without adrenaline 1:200,000) by ring block or field block around the abscess margin.
• For pilonidal abscess: off-midline (lateral) incision — this is a key technical distinction. A midline incision over the natal cleft heals poorly due to the constant movement and moisture of the area; a lateral elliptical incision off the midline achieves comparable drainage with significantly better wound healing rates per the ASCRS 2019 practice parameters.
• Adequate drainage — break up any loculations with a finger or probe.
• Irrigation with saline.
• Loose packing with ribbon gauze or wick; change every one to two days; wound heals by secondary intention over several weeks.

When to add antibiotics: IDSA 2014 provides clear guidance that antibiotics are not indicated as routine adjuncts after adequate I&D in uncomplicated abscess in immunocompetent adults. Antibiotics are indicated when:

• Surrounding cellulitis extends ≥5 cm from the abscess edge
• Systemic features are present (fever, tachycardia, raised CRP)
• The patient is immunocompromised (diabetes mellitus, HIV, on corticosteroid or immunosuppressant therapy)
• Multiple sites are present
• Drainage was anatomically limited or incomplete
• The patient has recurrent abscesses or a known MRSA exposure

First-line for standard cover: di/flucloxacillin 500 mg four times daily or cephalexin 500 mg four times daily for 5–7 days. For CA-MRSA risk, substitute trimethoprim-sulfamethoxazole (TMP-SMX) 160/800 mg twice daily or doxycycline 100 mg twice daily. Perianal abscesses require anaerobic cover — add metronidazole 400 mg twice daily.

B. Evidence on management — what the trials show

The evidence base for managing cutaneous abscess is clear and well-grounded. IDSA 2014 and a Cochrane systematic review of surgical interventions for pilonidal sinus both find:

• I&D is the primary treatment — antibiotics alone are inadequate for a fluctuant abscess
• Off-midline incision for pilonidal abscess produces better healing than midline incision — this is the recommended approach
• Antibiotics as routine adjuncts to uncomplicated abscess drainage do not improve outcomes in immunocompetent adults

For the CA-MRSA landscape, evidence supports TMP-SMX and doxycycline as effective oral options for skin and soft tissue infections caused by MRSA strains, with clinical cure rates comparable to beta-lactams for susceptible organisms. The CDC community-acquired MRSA guidelines reinforce empiric MRSA cover in high-risk patient populations and geographic clusters.

For recurrent and chronic pilonidal sinus, the Cochrane review and European Society of Coloproctology 2020 consensus support minimally invasive approaches over wide midline excision:

• Wide local excision with primary midline closure carries the highest recurrence rate and longest recovery — this approach is no longer recommended as first-line
• EPSiT (endoscopic pilonidal sinus treatment) uses endoscopic visualisation and tissue ablation; it carries lower morbidity and faster recovery than open surgery
• Bascom cleft lift and Karydakis flap produce low recurrence rates (~5–8%) by flattening the natal cleft — these flap procedures are the preferred choice for complex or recurrent disease

Hair removal for recurrence prevention: multiple randomised trials and meta-analyses find that laser depilation of the natal cleft region reduces pilonidal recurrence by approximately 50% compared to observation alone. This is now standard advice from the ASCRS 2019 guidelines and is increasingly offered as primary prevention in high-risk young men.

Decolonisation for recurrent S. aureus abscesses: mupirocin 2% nasal ointment twice daily for 5 days combined with chlorhexidine 4% body wash daily for 5 days reduces recurrent S. aureus skin infections. Household member treatment is appropriate when multiple family members are affected, consistent with IDSA 2014 recommendations.

C. GP action plan — the five-step approach

Step 1 — Confirm a drainable abscess. Fluctuance on palpation confirms a fluid collection. If uncertain, bedside ultrasound differentiates abscess from cellulitis. Cellulitis without fluctuance is not I&D territory — it requires systemic antibiotics alone.

Step 2 — Perform I&D under local anaesthetic. Use an off-midline lateral approach for pilonidal abscess. For a general cutaneous abscess, a linear incision over the point of maximal fluctuance is sufficient. Break up loculations, irrigate, and pack loosely.

Step 3 — Decide on antibiotics using IDSA criteria. In an otherwise well, immunocompetent adult with a well-drained abscess and minimal surrounding cellulitis, antibiotics add no benefit. Apply the criteria above — cellulitis ≥5 cm, systemic features, immunocompromise, incomplete drainage. Assess CA-MRSA risk and adjust cover accordingly. Send a wound swab if CA-MRSA is suspected.

Step 4 — Arrange wound care follow-up. Dressings should be changed daily or every second day. The wound heals by secondary intention and typically takes two to six weeks. The Australian Wound Management Association provides practical guidance on wound dressing selection for healing-by-secondary-intention wounds.

Step 5 — Address the long-term for pilonidal disease. Before the patient leaves, discuss hair removal (laser depilation) as the single most effective recurrence-prevention measure. For a second or subsequent pilonidal episode, or established chronic sinus, refer to a general or colorectal surgeon for EPSiT or Bascom cleft lift assessment. Do not offer re-drainage as a long-term strategy for recurrent pilonidal disease.

D. Australian operations — MBS, PBS, and referral pathways

MBS items:

• Item 23 — Level B consultation for assessment and procedure planning
• Item 36 / 44 — Longer Level C/D consultations for complex cases
• Item 30219 — Incision and drainage of abscess (GP-performable)
• Item 32500 — Excision of pilonidal sinus (specialist)
• Item 30068 / 30069 — Wide local excision (surgeon)
• Item 31350 — Endoscopic pilonidal sinus treatment (EPSiT) — availability is expanding in specialist centres
• Item 73807 — Pathology bundle (FBC, CRP, HbA1c when recurrent abscess warrants metabolic screen)
• Item 715 — Aboriginal and Torres Strait Islander Health Assessment

PBS prescribing:

• Di/flucloxacillin, cephalexin, TMP-SMX (Bactrim DS), doxycycline, clindamycin oral, metronidazole — all General Schedule; no Authority required
• Mupirocin 2% nasal ointment (Bactroban) — General Schedule; nasal decolonisation course
• Lignocaine 1% / 2% — General Schedule

Referral pathways:

• General surgeon / colorectal surgeon: for recurrent or chronic pilonidal sinus (EPSiT, cleft lift, Karydakis), complex perianal abscess, suspected fistula-in-ano
• Dermatologist: for recurrent skin abscesses with diagnostic uncertainty (rule out hidradenitis suppurativa), or unusual causative organisms
• Infectious diseases: for recurrent abscesses with immunodeficiency workup, confirmed PVL-positive MRSA clusters, or complex antimicrobial management

GP-performable procedures: Acute pilonidal abscess I&D and cutaneous abscess I&D are both within general practice procedural scope with appropriate equipment (procedure trolley, sterile technique, lignocaine, forceps, packing material, dressings) and consent documentation.

E. Special populations

Diabetes mellitus: Skin and soft tissue infections present atypically and progress more rapidly in people with diabetes. The surrounding cellulitis may be larger than apparent. Systemic features (fever, hyperglycaemia, raised white cell count) may be blunted. Use a lower threshold for IV antibiotics and inpatient management. Request HbA1c in any patient with recurrent abscesses to detect previously undiagnosed diabetes.

Community-acquired MRSA clusters: CA-MRSA is disproportionately prevalent in some Aboriginal and Torres Strait Islander communities and in settings with high antibiotic use or close contact (correctional facilities, sport). Apply empiric TMP-SMX or doxycycline cover when MRSA carriage is clinically suspected; obtain culture before commencing antibiotics where feasible.

Intravenous drug use (IVDU): Injection-site abscesses carry unusual causative organisms (including MRSA, Streptococcus, and Gram-negatives), and deeper involvement (septic thrombophlebitis, necrotising fasciitis) is more common. Harm reduction advice, hepatitis B/C and HIV testing, and a lower threshold for imaging and inpatient management are all appropriate.

Obesity: Deep natal cleft and increased friction are direct risk factors for pilonidal disease. Weight management discussion and addressing sedentary behaviour are relevant long-term recommendations alongside the procedural management.

Pregnancy: Antibiotic selection requires attention to safety. Di/flucloxacillin is compatible with pregnancy. TMP-SMX is generally avoided in the first trimester (folate antagonism) and near term (neonatal jaundice risk). Doxycycline is contraindicated after 12 weeks gestation. For pregnant women with MRSA risk, consult infectious diseases or obstetrics.

Children: Pilonidal disease is rare before puberty but cutaneous abscesses are common in children, particularly in the perianal and perineal area. Recurrent abscesses in a child warrant investigation for immunodeficiency (immunoglobulin levels, HIV if risk factors, neutropenia). Procedural I&D in children often requires careful topical or inhaled anaesthesia planning.

When to escalate

Contact emergency services or send to hospital on the same day for:

• Systemic sepsis: fever >38.5°C, heart rate >100, hypotension, confusion — intravenous antibiotics and admission are required
• Necrotising fasciitis: rapidly extending tissue death with dusky skin, crepitus, disproportionate pain, or skin necrosis — surgical emergency
• Perianal abscess with suspected deep (ischiorectal) extension or fistula — requires surgical examination under anaesthesia in theatre
• Failed office I&D or abscess in a high-risk anatomical location (face, hand, periorbital) — surgeon involvement

Arrange same-day or next-day general surgery review for:

• Abscess not adequately drained in the office setting
• Pilonidal abscess with extensive cellulitis requiring intravenous antibiotics and monitoring
• Recurrent pilonidal disease after two or more I&D procedures — refer for EPSiT or cleft lift assessment

What this article is and is not

This article provides educational information about pilonidal disease and skin abscess management based on current Australian guidelines including Therapeutic Guidelines, RACGP, and IDSA 2014. It is not a substitute for assessment by a healthcare professional and does not constitute personal medical advice.

Antibiotic regimens should be confirmed against current prescribing information and tailored to individual patient circumstances including allergy status, renal function, and local resistance patterns. Dr Hoe Bing Lo is an AHPRA-registered general practitioner (MED0001212640, FACRRM) practising in Australia. This article has not yet undergone specialist AHPRA review and is flagged accordingly.

---

Sources cited

1. Therapeutic Guidelines (eTG) — Skin infections
2. RACGP — Pilonidal disease and abscess management in general practice
3. IDSA 2014 — Practice Guidelines for Skin and Soft Tissue Infections (Stevens et al.)
4. ASCRS Practice Parameters for Pilonidal Disease 2019
5. European Society of Coloproctology Pilonidal Disease Consensus 2020
6. Cochrane — Surgical interventions for pilonidal sinus
7. NICE CKS — Boils, carbuncles, and staphylococcal carriage
8. Australian Wound Management Association — Wound dressings
9. CDC — Community-acquired MRSA guidelines
10. HealthDirect — Boils and skin abscesses